221
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Recent Advances in Clinical Proteomics Using Mass Spectrometry

, , &
Pages 1609-1615 | Published online: 20 Aug 2010

Bibliography

  • Holven KB , AukrustP, HolmT, OseL, NenseterMS. Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocystinemic subjects. Arterioscler. Thromb. Vasc. Biol. 22, 699–703 (2002).
  • McLerran D , GrizzleWE, FengZet al. Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. Clin. Chem. 54, 44–52 (2008).
  • Findeisen P , NeumaierM. Mass spectrometry-based clinical proteomics profiling: current status and future directions. Expert Rev. Proteomics6, 457–459 (2009).
  • Winter D , SeidlerJ, ZivYet al. Citrate boosts the performance of phosphopeptide analysis by UPLC–ESI-MS/MS. J. Proteome Res. 8, 418–424 (2009).
  • Bordeerat NK , GeorgievaNI, KlapperDGet al. Accurate quantitation of standard peptides used for quantitative proteomics. Proteomics9, 3939–3944 (2009).
  • Chen EI , HewelJ, Felding-HabermannB, YatesJRIII. Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT). Mol. Cell Proteomics5, 53–56 (2006).
  • Li QR , NingZB, TangJS, NieS, ZengR. Effect of peptide-to-TiO2 beads ratio on phosphopeptide enrichment selectivity. J. Proteome Res. 8, 5375–5381 (2009).
  • Tang J , LiuY, QiDet al. On-plate-selective enrichment of glycopeptides using boronic acid-modified gold nanoparticles for direct MALDI-QIT-TOF MS analysis. Proteomics9, 5046–5055 (2009).
  • Lebrecht A , BoehmD, SchmidtMet al. Surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry to detect breast cancer markers in tears and serum. Cancer Genomics Proteomics6, 75–83 (2009).
  • Petricoin EF , ArdekaniAM, HittBAet al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet359, 572–577 (2002).
  • Poon TC . Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev. Proteomics4, 51–65 (2007).
  • Voortman J , PhamTV, KnolJC, GiacconeG, JimenezCR. Prediction of outcome of non-small-cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling. Proteome Sci. 7, 34–48 (2009).
  • Djidja MC , ClaudeE, SnelMFet al. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections. J. Proteome Res. 8, 4876–4884 (2009).
  • Gygi SP , RistB, GerberSAet al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 10, 994–999 (1999).
  • Ross PL , HuangYN, MarcheseJNet al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics3, 1154–1169 (2004).
  • Byers HL , CampbellJ, van Ulsen Pet al. Candidate verification of iron-regulated Neisseria meningitidis proteins using isotopic versions of tandem mass tags (TMT) and single reaction monitoring. J. Proteomics73, 231–239 (2009).
  • Ong SE , BlagoevB, KratchmarovaIet al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics1, 376–386 (2002).
  • Krijgsveld J , KettingRF, MahmoudiTet al. Metabolic labeling of C. elegans and D. melanogaster for quantitative proteomics. Nat. Biotechnol. 21, 927–931 (2003).
  • Kellermann J . ICPL – isotope-coded protein label. Methods Mol. Biol. 424, 113–123 (2008).
  • Vaudel M , SickmannA, MartensL. Peptide and protein quantification: a map of the minefield. Proteomics10, 650–670 (2009).
  • Piersma SR , FiedlerU, SpanSet al. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum. J. Proteome Res. 9, 1913–1922 (2010).
  • Ryu S , GallisB, GooYAet al. Comparison of a label-free quantitative proteomic method based on peptide ion current area to the isotope coded affinity tag method. Cancer Inform. 6, 243–255 (2008).
  • Wiesner J , PremslerT, SickmannA. Application of electron transfer dissociation (ETD) for the analysis of posttranslational modifications. Proteomics8, 4466–4483 (2008).
  • Baek JH , KimH, ShinB, YuMH. Multiple products monitoring as a robust approach for peptide quantification. J. Proteome Res. 8, 3625–3632 (2009).
  • Kuzyk MA , SmithD, YangJet al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell Proteomics8, 1860–1877 (2009).
  • Whiteaker JR , ZhaoL, AndersonL, PaulovichAG. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol. Cell Proteomics9, 184–196 (2010).
  • Findeisen P , PeccerellaT, PostSet al. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool. Rapid Commun. Mass Spectrom. 22, 1223–1229 (2008).
  • Jessani N , NiessenS, WeiBet al. A streamlined platform for high-content functional proteomics of primary human specimens. Nature Methods2, 691–697 (2005).
  • Villanueva J , NazarianA, LawlorKet al. A sequence-specific exopeptidase activity test (SSEAT) for ‘functional’ biomarker discovery. Mol. Cell Proteomics7, 509–518 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.